Загрузка...
Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes
BACKGROUND: In spite of its rather specific name, glycogen synthase kinase-3 (GSK-3) is an eclectic cellular regulator that modulates an array of processes from nuclear transcription, to neurological functions and metabolism. The enzyme is also a focal point for diverse signaling pathways that act t...
Сохранить в:
| Опубликовано в: : | Expert Opin Ther Targets |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485462/ https://ncbi.nlm.nih.gov/pubmed/18781825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728222.12.10.1265 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|